State Of Wisconsin Investment Board Clene Inc. Transaction History

State Of Wisconsin Investment Board

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$3.95 - $7.53 $116,920 - $222,888	-29,600 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$6.83 - $13.58 $95,442 - $189,766	13,974 Added 89.43%	29,600 $202,000
Q2 2021 Aug 12, 2021	BUY	$6.98 - $13.33 $109,069 - $208,294	15,626 New	15,626 $176,000

230K

25K

Ticker CLNN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 63,502,000
Market Cap $279M
Description
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.